About
Schinecker studied genetics at the University of Salzburg. He earned a doctorate in molecular biology at New York University in 2003 and joined Roche the same year through a management development programme. He worked in marketing, sales, and general management in Austria, the United States, Sweden, and Germany, then led the Diagnostics division from 2019 to 2022. Other pharmaceutical chief executives on Whoo include David Ricks of Eli Lilly and Chris Boerner of Bristol Myers Squibb.
He served as interim head of the Pharmaceuticals division in early 2023. In 2025 he became chair of the Biopharmaceutical CEOs Roundtable and joined the board of Chugai Pharmaceutical in Japan.
Whoo compiled this page from public sources: Roche media release, 22 October 2026, Roche biography, Roche Executive Committee page, Wikipedia. It is not affiliated with or endorsed by Thomas Schinecker. Are you Thomas Schinecker? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17. Photo: Ministerio de la Presidencia, Gobierno de España, CC BY 3.0, via Wikimedia Commons.
Want a page like this? Create yours from your résumé.
Experience
Chief Executive Officer — Roche Group
2023 – Present | Basel, Switzerland
- Leads the group since March 2023, succeeding Severin Schwan
- President of the International Federation of Pharmaceutical Manufacturers and Associations since 2025
- Led the division in early 2023
- Joined the Corporate Executive Committee in 2019
- Held country general manager roles; earlier head of marketing and sales in Austria
- Joined Roche in 2003
Interim CEO, Pharmaceuticals Division — Roche
2023
CEO, Diagnostics Division — Roche
2019 – 2022
General Manager, Roche Diagnostics Sweden and Germany — Roche
Management Development Programme — Roche
2003
Education
PhD in Molecular Biology — New York University
2003
MS in Molecular Biology — New York University
2000
Bachelor's degree in Genetics — University of Salzburg
1997